Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.
Publication
, Journal Article
Aguirre, FV; Topol, EJ; Anderson, KM; Kleiman, NS; Weisman, HF; FitzPatrick, SE; Califf, RM
Published in: J Invasive Cardiol
1996
Duke Scholars
Published In
J Invasive Cardiol
EISSN
1557-2501
Publication Date
1996
Volume
8 Suppl B
Start / End Page
21B / 29B
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Aguirre, F. V., Topol, E. J., Anderson, K. M., Kleiman, N. S., Weisman, H. F., FitzPatrick, S. E., & Califf, R. M. (1996). Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. J Invasive Cardiol, 8 Suppl B, 21B-29B.
Aguirre, F. V., E. J. Topol, K. M. Anderson, N. S. Kleiman, H. F. Weisman, S. E. FitzPatrick, and R. M. Califf. “Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.” J Invasive Cardiol 8 Suppl B (1996): 21B-29B.
Aguirre FV, Topol EJ, Anderson KM, Kleiman NS, Weisman HF, FitzPatrick SE, et al. Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. J Invasive Cardiol. 1996;8 Suppl B:21B-29B.
Aguirre, F. V., et al. “Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.” J Invasive Cardiol, vol. 8 Suppl B, 1996, pp. 21B-29B.
Aguirre FV, Topol EJ, Anderson KM, Kleiman NS, Weisman HF, FitzPatrick SE, Califf RM. Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. J Invasive Cardiol. 1996;8 Suppl B:21B-29B.
Published In
J Invasive Cardiol
EISSN
1557-2501
Publication Date
1996
Volume
8 Suppl B
Start / End Page
21B / 29B
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology